These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 7671392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A single lesion showing features of pigmented eccrine poroma and poroid hidradenoma.
    Chiu HH, Lan CC, Wu CS, Chen GS, Tsai KB, Chen PH.
    J Cutan Pathol; 2008 Sep; 35(9):861-5. PubMed ID: 18422687
    [Abstract] [Full Text] [Related]

  • 5. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
    Tateyama H, Eimoto T, Tada T, Inagaki H, Nakamura T, Yamauchi R.
    Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
    [Abstract] [Full Text] [Related]

  • 6. Benign and malignant eccrine poroma--a flow cytometric comparison.
    Hagler J, Trattner A, Nativ O, Hauben DJ, David M.
    Isr J Med Sci; 1996 Dec; 32(12):1151-3. PubMed ID: 9007142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Poroid hidradenoma].
    Monteagudo B, Iglesias B, de la Torre C, Paredes C, Vázquez-Blanco M, Ginarte M, Labandeira J.
    Actas Dermosifiliogr; 2005 Dec; 96(6):398-9. PubMed ID: 16476263
    [Abstract] [Full Text] [Related]

  • 10. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B, Bethwaite PB, Thornton A, Ribas JL.
    Cancer; 1995 Jun 01; 75(11):2714-9. PubMed ID: 7743475
    [Abstract] [Full Text] [Related]

  • 11. Malignant eccrine acrospiroma with metastasis to the parotid.
    Holden B, Colome-Grimmer M, Savage C, Stierman K, Pou AM.
    Ear Nose Throat J; 2002 May 01; 81(5):352-5. PubMed ID: 12025008
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC, Dublin EA, Camplejohn RS, Levison DA.
    Anal Cell Pathol; 1995 Jul 01; 9(1):45-52. PubMed ID: 7577754
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eccrine porocarcinoma of the upper eyelid.
    Jain R, Prabhakaran VC, Huilgol SC, Gehling N, James CL, Selva D.
    Ophthalmic Plast Reconstr Surg; 2008 Jul 01; 24(3):221-3. PubMed ID: 18520840
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical demonstration of myoepithelial cells in sweat gland carcinomas.
    Wach F, Hein R, Kuhn A, Landthaler M, Krieg T, Eckert F.
    Br J Dermatol; 1994 Apr 01; 130(4):432-7. PubMed ID: 8186107
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS.
    Cancer; 1996 Nov 01; 78(9):1881-7. PubMed ID: 8909306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.